Navigation Links
DURECT Signs Long Term Excipient Supply Agreement With King Pharmaceuticals for REMOXY(R)
Date:8/27/2009

CUPERTINO, Calif., Aug. 27 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.

(Logo:http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

"While we've been providing King with these key excipients starting in 2008, we're pleased to have now entered into this long term arrangement with King that formalizes the details of our supply agreement," stated James E. Brown, DURECT's President and CEO. "Given King's strong presence in pain management and commitment to be a leader in the development of products designed to reduce the potential for misuse and abuse, we look forward to supporting King's efforts to bring REMOXY to market."

REMOXY, based on DURECT's ORADUR(TM) technology, is an investigational drug that is a unique, controlled release formulation of oxycodone for moderate-to-severe chronic pain designed to reduce potential risks of unintended use. In mid-2008, an NDA for REMOXY was accepted by the FDA and was granted Priority Review. In December 2008, the FDA issued a Complete Response Letter related to REMOXY. In July 2009, King Pharmaceuticals met with the FDA to discuss the Complete Response Letter and King Pharmaceuticals has stated that it anticipate
'/>"/>

SOURCE DURECT Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma
2. DURECT Corporation Announces Second Quarter 2009 Financial
3. DURECT to Present at the BMO Capital Markets Healthcare Conference
4. DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call
5. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
6. DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call
7. DURECT to Participate in Cowen and Company Healthcare Conference
8. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
9. DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call
10. DURECT Corporation to Participate in Upcoming Healthcare Conferences
11. DURECT Corporation to Participate in Upcoming Healthcare Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofMagnetic...entificInc.,aleadingproviderofsoftwareenablingtech...t4DAdvancedVisualizationsoftware. ,, Thisinnova...tbasedmedicalimagingofferinginthemarket.CalgarySci...taccess-requiringnosoftwaredownload,andrunsonanyMa...
(Date:11/25/2009)...anksgivingmealswillbedeliveredtoapproximately1,000...aithInAction/VolunteerActionforAging,aprogramopera...Plan.Formorethan17yearstheseorganizationshavegathe...alstoseniorsinneedinLongBeach,Lakewood,SignalHill,..., "Ourwarmholidaymealsaredeliveredtopeoplewhohavem...
(Date:11/25/2009).../--TheBlackAIDSInstituterecentlyheldBoardofDirecto..., ThenewBoardMembersareahighlydiversegroupoflea...rnmenthealthprograms,editorial,andbusinessentrepre...backgroundsincludingbothheterosexualandgayBlackmen...ngmultipleagegroups. ,, (Photo: http://www.news...
(Date:11/25/2009)...dPressJoinEfforttoEducate ,, MEMPHIS,Tenn.,Nov...ipolarFoundationandtheMedicAlertFoundationreceivea...whichisnowbeingwidelyacceptedasapreventivehealthca...arFoundationreceivedaproclamationofendorsementviaF...ianaMitchLandrieu.TheNationalBipolarFoundationstat...
(Date:11/25/2009)...cally significant survival benefit from adjuvant t...R)-positive tumors had high levels of phosphorylat...according to a brief communication published onlin...er Institute . , Approximately 50% of breast car...udies have shown that ER-alpha S118-P is required ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3
... the thickness of the grey matter in the cortical ...ed thinning// of cortical region of the brain. Mai...rain is necessary for the proper functioning of th...ive and emotional processing, the researchers repo...
...educe world energy demand should it evolve into a ...ibly by more than 1-million barrels a day//. Wo...ording to data issued by the US Energy Information...by well over 1-million barrels per day,” the US in...
... a Singaporean, who had a bone marrow transplant i...ant operation without taking drugs to prevent reje... kidney failure four years ago. Two years later, d... Department of Medicine (NUH), "MDS is a pre-leuke...
...d are advised to be consumed; in the same league a...rient supplements help fight cancer even though th...particularly when you want to sell nutrition suppl...ion, helped save his neighbor known as “D.H.” with...
...d of trauma care are very few compared to other me...are would help in improving emergency treatments a...f deaths caused by accidents//. More than 10,...s, writing in this week's BMJ, argue that there is...
...rnia are finding out a new theory on the formation...hich connect other brain regions forming a new pro...eet of around 10 billion neurons divided into dist...haped by the environment? The protomap and protoco...
Other Medicine News:Health News:Meditation Maintains And Thickens The Grey Matter Of The Brain 2Health News:Bird Flu Likely To Reduce World Energy Demand 2Health News:Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs 2Health News:Another Benefit For Human Health Attributed To Omega-3-Fats 2Health News:Scientists breaking theory of cortex formation 2
(Date:11/25/2009)...ILL,N.C.,Nov.25/PRNewswire/--CempraPharmaceuticals...ntandchiefexecutiveofficer,willpresentatthePiperJa...ecember1,2009,atTheNewYorkPalaceHotelinNewYorkCity...oleadingantibioticclinicalprogramsforthetreatmento...tCempraPharmaceuticals ,, Foundedin2006,Cempra...
(Date:11/25/2009)...NVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentryx,In...eCompany,sPROTECT-1(theProspectiveRandomizedOralTh...(TM)(CCX282-B)inpatientswithmoderate-to-severeCroh...lesafetyandtolerabilityprofile.Thestudydemonstrate...severityasdefinedasa70-pointdecreaseintheCrohn,sDi...
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--Vermillion,I...ditsPlanofReorganizationandDisclosureStatementtoda...rtfortheDistrictofDelaware.Ahearingtoconsiderappro...December8,2009,withthehearingontheconfirmationofth...fortheCompanytopayallclaimsinfull.ThePlanisexpecte...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 1Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 2Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 3Wyeth Announces Holder Right to Surrender Convertible Debentures 12653 4Torn Surgical Gloves Put Patients at Risk for Infection 49069 1Torn Surgical Gloves Put Patients at Risk for Infection 49069 2Providing health insurance for US children would be cheaper than expected study says 49065 1Providing health insurance for US children would be cheaper than expected study says 49065 2
...NEW YORK, July 12, 2007 /PRNewswire-FirstCall/ -- ...ibb Company today,announced results from an open-l...s a taxane and carboplatin in the first-line,treat...CLC). The,study did not meet its primary endpoint ...an independent radiology review,committee (IRRC). ...
... Helen Londe, M.D. Contributing Editor , ,Ce...sease of the small intestine that is triggered in ...f the gluten-containing grains wheat, rye, barley,...sult from the activation of both a T-cell and B-ce...n, villous atrophy, and crypt hyperplasia, and is ...
Other Medicine Technology:Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9Non-Invasive Diagnostic Tests for Celiac Disease 2Non-Invasive Diagnostic Tests for Celiac Disease 3
Ultrafin™ Stirrup
6"H Plexiglass Armshield
Armboards
3D/SwingerOperating Table Clamp
Medicine Products: